✦ LIBER ✦

PMS10 THE COST-EFFECTIVENESS OF ABATACEPT VERSUS RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: A PERSPECTIVE OF THE CANADIAN PUBLICLY FUNDED HEALTH CARE SYSTEM

✍ Scribed by Y Yuan; M Maier-Moldovan; R Maclean; GJ L'Italien

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Indirect cost-effectiveness analyses of

✍ Yuan, Yong; Trivedi, Digisha; Maclean, Ross; Rosenblatt, Lisa 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 488 KB

PMS29 CANADIAN COST-EFFECTIVENESS ANALYS

✍ D Zou; O Desjardins; N Tsao; R Goeree 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PMS9 COST-EFFECTIVENESS OF ABATACEPT IN

✍ M Maier-Moldovan; Y Yuan; R Maclean; GJ L'Italien 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PMS22 COST-EFFECTIVENESS OF THE USE OF E

✍ X Gao; S Hwang; KT Carpiuc; JM Stephens; R Sato; A Singh; R Rivera; E García; H 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

PCN64 COST-EFFECTIVENESS ANALYSIS OF SOR

✍ N Muszbeck; U Munir; H Vioix; A Schiola; A Valderrama; V Teich 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

PCN68 COST-EFFECTIVENESS ANALYSIS OF SOR

✍ N Muszbeck; H Vioix; U Munir; A Schiola; A Valderrama; V Teich 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB